# Fortis says it has no role in Daiichi-Singh Brothers dispute after SC allows audit

2026-09-27T13:16:35+00:00 | Governance | Indian Opinion Desk

Corroboration: 3 independent outlets

Fortis Healthcare said on 27 September it is a 'complete stranger' to the legal dispute between Daiichi Sankyo and the Singh Brothers, after the Supreme Court on 25 September cleared the way for a forensic audit of the company. The Supreme Court disposed of Fortis's petition against a Delhi High Court order directing the audit, clarifying that the High Court's observations were tentative and that the audit must be conducted independently. Fortis, in a stock exchange filing, said it had no control over the transfer of shares by its erstwhile promoters and did not receive any money from the sale of their shareholding. The dispute stems from Daiichi Sankyo's efforts to enforce a Rs 3,500 crore arbitral award against former Fortis promoters Malvinder and Shivinder Singh. The Delhi High Court had appointed a forensic auditor in August to trace transactions involving the Singh brothers and Fortis related to the alleged dissipation of shares. Fortis emphasized that the High Court did not impose any monetary liability on the company, and it is confident the independent audit will confirm its position. The company also noted that its current promoter, Northern TK Venture, part of the IHH Healthcare Berhad group, invested through a fresh issue of shares in November 2018, after the Singh brothers had left the board.

## Indian Opinion Analysis

All three sources, Livemint, ETHealthworld, and ET, relay Fortis's defensive filing with near-identical neutral reporting, but Livemint adds market reaction with a technical analyst's downside view, framing the story partly through investor caution. ETHealthworld and ET focus solely on the company's legal defense and regulatory timeline. The coverage is uniform straight reporting, no source adopts a critical or pro-government stance on the underlying dispute. The key takeaway is that Fortis's clean-hands argument will now be tested by an independent forensic audit, with market watchers expecting share price pressure until the audit clarifies whether any liability attaches to the company. The audit's findings, when submitted, will be the next concrete signal.

## Coverage

- livemint.com (neutral report) <https://www.livemint.com/market/stock-market-news/fortis-says-it-is-complete-stranger-to-daiichi-singh-brothers-dispute-after-sc-allows-forensic-audit-shares-in-focus-11790503647988.html>
  Leads with company denial and adds market analyst commentary on stock downside
- health.economictimes.indiatimes.com (neutral report) <https://health.economictimes.indiatimes.com/news/hospitals/fortis-says-no-role-in-daiichi-singh-brothers-dispute-as-sc-allows-forensic-audit/134518549>
  Straight reporting of Fortis regulatory filing, no added analyst or market angle
- economictimes.indiatimes.com (neutral report) <https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/fortis-defends-itself-after-supreme-court-allows-forensic-audit-says-it-was-complete-stranger-to-daiichi-singh-brothers-dispute/articleshow/134517489.cms>
  Straight reporting with emphasis on Supreme Court order and company's legal defense

Tags: Daiichi Sankyo, Fortis Healthcare, IHH Healthcare, Singh Brothers, Supreme Court
Canonical: https://indianopinion.org/fortis-says-it-is-complete-stranger-to-daiichi-singh-brothers-dispute/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/fortis-says-it-is-complete-stranger-to-daiichi-singh-brothers-dispute/#story-in-brief
